Mental Health Cues the NCLEX-PN Tests Most Often
Mental health content accounts for approximately 9–15% of the NCLEX-PN. The questions test whether the future LPN can recognize behavioral cues, apply therapeutic communication, understand medication safety in psychiatric conditions, and identify when escalation is needed. Unlike medical topics, the factory framework here applies to the neurotransmitter supply chain — the chemical messaging system of the brain factory.
Key Neurotransmitter–Disorder Connections
| Neurotransmitter | Factory Role | Deficiency/Excess State | Drug Targets |
|---|---|---|---|
| Dopamine | Reward, movement, motivation messaging | Excess → schizophrenia (positive symptoms); Deficit → Parkinson's | Antipsychotics block dopamine; L-dopa restores it |
| Serotonin | Mood regulation, sleep, appetite | Deficit → depression, anxiety | SSRIs (fluoxetine, sertraline) increase serotonin availability |
| GABA | Brain's "calm down" signal — inhibitory | Low GABA → anxiety, seizures | Benzodiazepines enhance GABA; risk of respiratory depression |
| Norepinephrine | Alertness, fight-or-flight activation | Excess → anxiety, PTSD; Deficit → depression | SNRIs target both serotonin and norepinephrine |
First-generation antipsychotics (haloperidol, chlorpromazine) block dopamine broadly, causing extrapyramidal side effects (EPS): muscle rigidity, tremor, akathisia (restless pacing), tardive dyskinesia (involuntary repetitive movements — potentially irreversible). Collect and report any involuntary movement cues immediately.
Second-generation antipsychotics (olanzapine, quetiapine, risperidone) have lower EPS risk but carry metabolic syndrome risk — monitor weight, blood glucose, and lipids.
Ready to see this in action?
NursingAcademics is built around the Cell Factory Method from Phase 1 through Phase 3. Every system, every medication, every cue is explained through the same equation.
Explore the Cell Factory tutorials